BioPharma Credit Investment Corporation

Back to the presentation.

Good afternoon and welcome to the Biopharma Credit PLC investor presentation.

Throughout this recorded presentation, investors will be in listen-only mode.

Questions are encouraged and could be submitted at any time via the Q&A tab situated on the right-hand corner of your screen.

Pedro, good afternoon, sir.

Thank you very much, and thank you all for joining us.

This is the presentation for the half-yearly results that were announced yesterday for Biopharma Credit PLC.

The slides are on the website, bpcruk.com, as well as the full results for the half-year.

Hello and welcome to the John Barron Portfolios podcast, brought to you by johnbarronportfolios.co.uk.

I am John Huben and I'm very pleased to be joined today by Pedro Gonzalez de Cosio, who is one of the managers of the Biopharma Credit Investment Trust, which is an interesting holding within the John Barron Portfolios.

Welcome, Pedro.

Thank you very much, John, for having me

So as I say, it's an interesting trust.

That's something a little bit different to a lot of the investment companies that we invest in.

But perhaps, you know, start us off, Pedro, by introducing yourself and tell us a little bit about Biopharma Credit.

What does it do? What are its objectives?